InvestorsHub Logo
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Re: wallstone1 post# 220

Sunday, 04/27/2014 8:29:22 PM

Sunday, April 27, 2014 8:29:22 PM

Post# of 1014
I might agree with you but Dexcel Pharma was a lead investor in the secondary & now owns approximately 20% of Cynapsus. I doubt they would have committed additional funds if they felt they were going to be diluted again.